Literature DB >> 16178948

Hormones, menstrual distress, and migraine across the phases of the menstrual cycle.

Jeffrey L Kibler1, Jamie L Rhudy, Donald B Penzien, Jeanetta C Rains, G Rodney Meeks, William Bennett, Katherine M Dollar.   

Abstract

OBJECTIVE: The primary objectives of the present study were to (1) contrast reproductive hormone levels and ratings of menstrual distress of female migraineurs with those of a control group in each menstrual cycle phase, (2) examine correlations between hormone levels and migraine frequency, severity, and migraine-related disability, and (3) examine correlations between menstrual distress and migraine frequency, severity, and migraine-related disability. A secondary objective was to evaluate the validity of a migraine disability measure modified to reflect 7-day recall.
BACKGROUND: Further controlled, prospective study is needed regarding the temporal relationships between reproductive hormones at each stage of the menstrual cycle and fluctuations in migraine activity across the cycle.
METHODS: Twenty-three women (17 with migraine, 6 control participants) completed laboratory hormone assays and measures of menstrual distress and disability at each phase of one menstrual cycle, and monitored their headache activity daily during the same cycle. Results.-The migraine group evidenced lower premenstrual luteinizing hormone and more menstrual distress symptoms at each phase of the menstrual cycle. Hormones were associated with migraine activity and disability within cycle phases, and across phases in a time-lagged manner. Menstrual distress was associated with ovulatory phase migraine activity and with migraine-related disability across the menstrual cycle. A retrospective 7-day migraine disability measure appeared to be a consistently valid index.
CONCLUSIONS: Both reproductive hormones and menstrually related distress appear to predict migraine activity and disability. These associations were evident not only for perimenstrual migraine, but also for migraine at each phase of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178948     DOI: 10.1111/j.1526-4610.2005.00241.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  8 in total

1.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.

Authors:  Serena L Orr; Abigail Turner; Marielle A Kabbouche; Paul S Horn; Hope L O'Brien; Joanne Kacperski; Susan LeCates; Shannon White; Jessica Weberding; Mimi N Miller; Scott W Powers; Andrew D Hershey
Journal:  Headache       Date:  2019-01-23       Impact factor: 5.887

Review 3.  Prevention and treatment of menstrual migraine.

Authors:  E Anne MacGregor
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

Review 4.  Perimenstrual headaches: unmet needs.

Authors:  E A MacGregor
Journal:  Curr Pain Headache Rep       Date:  2008-12

5.  Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles.

Authors:  Jelena M Pavlović; Amanda A Allshouse; Nanette F Santoro; Sybil L Crawford; Rebecca C Thurston; Genevieve S Neal-Perry; Richard B Lipton; Carol A Derby
Journal:  Neurology       Date:  2016-06-01       Impact factor: 9.910

6.  The relationship between food frequency and menstrual distress in high school females.

Authors:  Soheila Mohamadirizi; Masoumeh Kordi
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Nov-Dec

7.  Menstrual Cycle Variations in Gray Matter Volume, White Matter Volume and Functional Connectivity: Critical Impact on Parietal Lobe.

Authors:  Timothy J Meeker; Dieuwke S Veldhuijzen; Michael L Keaser; Rao P Gullapalli; Joel D Greenspan
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 5.152

8.  Giving Researchers a Headache - Sex and Gender Differences in Migraine.

Authors:  Linda Al-Hassany; Jennifer Haas; Marco Piccininni; Tobias Kurth; Antoinette Maassen Van Den Brink; Jessica L Rohmann
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.